The real plague affecting science research? It isn't fraud
Science fraud draws attention, but most scientists think it’s a far lesser threat to their field than the many times researchers cut corners.
opinion articles
Send us a link
Science fraud draws attention, but most scientists think it’s a far lesser threat to their field than the many times researchers cut corners.
In an era of online discussion, debate must remain nuanced and courteous.
From clarity to confusion, Rebecca Pool looks at the highs and lows of data sharing in scholarly publishing
If politicians can lie without condemnation, what are scientists to do? Kathleen Higgins offers some explanation.
The Big Data era, the impact of data science and its impact biological research and healthcare: interview with Phil Bourne.
But grave challenges remain before the promise of individually tailored medicine becomes reality.
Without access to large companies' datasets or the expertise to analyse them, research is confronted with a replication crisis and is vulnerable to commercial motivations.
The winners in Trump's America were likely to be the defence industry, oil and energy, private prisons, and pharmaceutical manufacturers. Not health. What should be the response of the public health community?
Physicists and scientific computing experts prepare for an onslaught of petabytes.
Will F1000Research and Wellcome Open Research be replacing journals and editors?
In a fractured world, the humanities are key to an understanding of others.
Researchers naturally want their work to make a difference, but the sad fact is that it often has little influence beyond academia
Driving progress and building on success at the National Institutes of Health
The traditional mode of publishing scientific research faces much criticism – primarily for being too slow and sometimes shoddily done. Maybe fewer publications of higher quality is the way forward.
Nine experts reflect on where researchers should direct their efforts during the next US administration.
Top science and tech talent could choose to set up in other countries that are more hospitable to their work.
Neuroscientist Ana Mingorance’s experience highlights some pointers for successfully making the move to industry.
The story of La Paillasse: an open lab which aims to cut out the intermediaries and create a much more open way of doing research, enabling to fast-prototype solutions to scientific problems.
The knowledge that we produce in our publicly funded works belongs to humankind and must not be locked up behind pay-walls— newly submitted papers should be open-access and older ones open-archive.
How should the scientific publication process be rethought to be more meritocratic?